SCHEMBL19620531

SCHEMBL19620531

NC1=C(OS(=O)Cc2ccccc2)C(=O)C(c2cccnc2)O1

nearest known ligand 0.39

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
MAPT P10636 3/20 0.39
KDM4E B2RXH2 2/20 0.39
POLB P06746 2/20 0.39
TP53 P04637 1/20 0.38
MDM2 Q00987 1/20 0.38
ALDH1A1 P00352 4/20 0.37
CYP19A1 P11511 2/20 0.35
USP2 O75604 1/20 0.35
MAPK1 P28482 1/20 0.35
CASP1 P29466 1/20 0.35
TSHR P16473 2/20 0.35
PKM P14618 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.34
CYP2A6 P11509 3/20 0.33
CYP3A4 P08684 1/20 0.33
FPR1 P21462 1/20 0.33
NPSR1 Q6W5P4 1/20 0.32
RXFP1 Q9HBX9 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19620621 0.89 MAPT (0.49) MAPTKDM4EPOLBTP53ALDH1A1
SCHEMBL22902015 0.84 PTAFR (0.37) MAPTKDM4ETP53MDM2ALDH1A1
SCHEMBL20367974 0.81 MAPT (0.41) MAPTKDM4EPOLBMDM2ALDH1A1
SCHEMBL15627599 0.81 KDM4E (0.41) MAPTKDM4EPOLB
SCHEMBL20368252 0.81 MAPT (0.39) MAPTKDM4EPOLBTP53MDM2
SCHEMBL22902083 0.81 KDM4E (0.39) MAPTKDM4EPOLBALDH1A1CYP19A1
SCHEMBL19620541 0.81 KDM4E (0.37) MAPTKDM4EPOLBCYP19A1CYP3A4
SCHEMBL19620538 0.81 KDM4E (0.37) MAPTKDM4EPOLBCYP3A4
SCHEMBL19620623 0.80 MAPT (0.40) MAPTKDM4EPOLBTP53ALDH1A1
SCHEMBL19620620 0.79 LMNA (0.38) MAPTKDM4EPOLBALDH1A1CYP19A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2897607-B1 INHIBITORS OF BETA-HYDROLASE FOR TREATMENT OF CANCER RHODE ISLAND HOSPITAL (US) 2017-11-22 EP disclosed